London, UK, 5th Feb 2022, ZEXPRWIREThe 10 best dividends growth stocks for this month are presented below:

The criteria the broker from FinancialCentre Oleg Nevsky has used was a double-digit 5-year total return [TTR] percentage as well as having discounted investment grade status in DVK Quality Snapshots’ database which provides investors access through transparency. This allows users greater insight into what they’re investing their money into before purchase because it will show you how well each company has performed over time relative those peers who do not provide such data directly but still offer some type of indexing option like Standard & Poor’s 500 Index +0.7% return on average yield for this month.

A lot of the criteria companies have to meet in order to be number one can’t even be seen at a glance, so Analysts recommend taking a look at their information before making your decision on whether they’re worth more research or not. At least you’ll know there’s some degree of certainty that these will probably perform well over time and had better since they’ve already been through the approval process with DVK.

One thing to keep in mind is that each company may have a different payout ratio but if it’s too high for investor’s preference then they won’t list them because investors purchasing shares would risk losing some dividend growth potential which can make a big difference overtime if compounded correctly.

Here are the stocks we need keep our eye on:

Medtronic: Medtronic, a company that manufactures and sells device-based medical therapies to hospitals throughout the world. The Dublin-headquartered business was founded in 1949 with four different groups: Cardiac & Vascular Group; Minimally Invasive Therapies group which includes surgical devices such as those used for heart operations or cataracts removal surgeries among others things); Restorative Therapy range refers specifically towards bone grafts used after accident news events like broken bones where there’s need of healing fast but without extensive trauma done on either side (this can take months) and finally Orphan Disease group which includes the treatments given to patients suffering from disease not well-known among doctors, nurses and general public.

Medtronic’s stock is currently priced at 50.78. In 2015 Medtronic bought Covidien for 23 billion dollars in a cash and share deal which made it one of the biggest medical device companies in the world channeling over 30% of its revenues from overseas markets where competition was tougher but also a lot more rewarding when performing well after a year or two during product launch cycles.

Dividend Yield: 2.84% TTR [Trailing Twelve Months] Annual Dividend Payout: $1.36 [$4.72 Projected 5 Year Annualized Dividend Growth]: 27.59%

P/E Ratio: 19.15 TSE Symbol: MDT

The stock’s dividend has grown by an average of 17.47% per year over the last five years, indicating that it is likely to continue raising dividends at that rate for the foreseeable future. The rating given by DVK Quality Snapshots is B+ with a price target of 91.50 which would indicate a potential capital gain in addition to a share price increase based on a combination of historical data in all companies their analysts have ever reviewed since 2011 going forward if they hold true during this month end analysis period and beyond into 2017 before next rebalancing process happens again in December.

Gap : Gap, Inc., together with its subsidiaries, operates as an apparel retail company worldwide. The company’s Clothing and Accessories segments offer casual apparel for men, women, children, babies, and toddlers; denim products; and accessories under the Gap, Old Navy, Banana Republic, Piperlime (closed in 2016), Athleta, Intermix (closed in 2016), Forth & Towne (closed in 2015), and Hill City (flagship stores) brands primarily through company-operated stores. Its Manufacturing segment provides denim products to customers

The stock has experienced a rough period over the last couple of months losing around 12% since January 27th closing at 31.78 on March 3rd showing some investor disinterest due to economic implications like the recent plunge in oil prices since it’s heavily reliant on selling items like coats and winter month related goods, plus it runs into trouble when Fuel costs go up which they have.

One of the most reliable things for this company is its ability to raise dividends every year, .67 increase last year was approved by board members with another projected 2% profits growth estimated which will lead to another annualized 7% dividend increase for 2017 giving investors a great opportunity to buy in right now at $31.78 per share earning an attractive 3.34% yield based on trailing twelve months totals.

Dividend Yield: 3.34% TTR [Trailing Twelve Months] Annual Dividend out: $0.67 [$2.31 Projected 5 Year Annualized Dividend Growth]: 7.32%

P/S Ratio: 1.60 TSE Symbol: GPS

Gap’s dividend has grown by an average of 6.99% per year over the last five years, indicating that it is likely to continue raising dividends at that rate for the foreseeable future.

Disclaimer: Our content is intended to be used for informational purposes only. It is very important to do your own research before making any investment based on your own personal circumstances. You should take independent financial advice from a professional in connection with, or independently research and verify, any information that you find on this article and wish to rely upon, whether for the purpose of making an investment decision or otherwise.